| Dr Euisoo S Kim, MD | |
|
7620 York Rd, Towson, MD 21204-7508 | |
| (410) 337-1660 | |
| Not Available |
| Full Name | Dr Euisoo S Kim |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 7620 York Rd, Towson, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245214600 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | D0025504 (Maryland) | Primary |
| Entity Name | First Colonies Anesthesia Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740218767 PECOS PAC ID: 8426039744 Enrollment ID: O20040525000119 |
News Archive
Curemark, LLC,, a drug research and development company focused on the treatment of neurological diseases, announced that the company has opened clinical trial enrollment for CM-AT, its autism treatment, at the University of Pittsburgh and the Alexian Brothers Behavioral Health Hospital in Hoffman Estates, Illinois, near Chicago. A total of 12 sites nationwide are recruiting patients for CM-AT Phase III clinical trials.
A multicenter team of researchers has identified an enzyme key to the survival and spread of glioblastoma cancer cells that is not present in healthy brain cells, making the enzyme a promising therapeutic target.
A new preclinical model of pulmonary arterial hypertension may lead to improved research and ultimately better therapies for this life-threatening problem, according to its developers, researchers at the University of South Alabama.
UBM Medica US announces that Endocrinology Network, a leading online community for endocrinologists and other clinicians who treat patients with T2DM offers comprehensive and up-to-date coverage of the sodium glucose cotransporter 2 (SGLT2) inhibitors.
The Ensign Group, Inc., the parent company of the Ensign group of skilled nursing, rehabilitative care services and assisted living companies, today announced that its Board of Directors has declared a quarterly cash dividend of $0.06 per share of Ensign common stock, payable on or before January 31, 2012 to shareholders of record as of December 31, 2011.
› Verified 5 days ago
| Entity Name | St. Agnes Healthcare, Inc. |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1003079799 PECOS PAC ID: 9830092733 Enrollment ID: O20080923000209 |
News Archive
Curemark, LLC,, a drug research and development company focused on the treatment of neurological diseases, announced that the company has opened clinical trial enrollment for CM-AT, its autism treatment, at the University of Pittsburgh and the Alexian Brothers Behavioral Health Hospital in Hoffman Estates, Illinois, near Chicago. A total of 12 sites nationwide are recruiting patients for CM-AT Phase III clinical trials.
A multicenter team of researchers has identified an enzyme key to the survival and spread of glioblastoma cancer cells that is not present in healthy brain cells, making the enzyme a promising therapeutic target.
A new preclinical model of pulmonary arterial hypertension may lead to improved research and ultimately better therapies for this life-threatening problem, according to its developers, researchers at the University of South Alabama.
UBM Medica US announces that Endocrinology Network, a leading online community for endocrinologists and other clinicians who treat patients with T2DM offers comprehensive and up-to-date coverage of the sodium glucose cotransporter 2 (SGLT2) inhibitors.
The Ensign Group, Inc., the parent company of the Ensign group of skilled nursing, rehabilitative care services and assisted living companies, today announced that its Board of Directors has declared a quarterly cash dividend of $0.06 per share of Ensign common stock, payable on or before January 31, 2012 to shareholders of record as of December 31, 2011.
› Verified 5 days ago
| Entity Name | Francu One Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194972588 PECOS PAC ID: 1658437058 Enrollment ID: O20090311000028 |
News Archive
Curemark, LLC,, a drug research and development company focused on the treatment of neurological diseases, announced that the company has opened clinical trial enrollment for CM-AT, its autism treatment, at the University of Pittsburgh and the Alexian Brothers Behavioral Health Hospital in Hoffman Estates, Illinois, near Chicago. A total of 12 sites nationwide are recruiting patients for CM-AT Phase III clinical trials.
A multicenter team of researchers has identified an enzyme key to the survival and spread of glioblastoma cancer cells that is not present in healthy brain cells, making the enzyme a promising therapeutic target.
A new preclinical model of pulmonary arterial hypertension may lead to improved research and ultimately better therapies for this life-threatening problem, according to its developers, researchers at the University of South Alabama.
UBM Medica US announces that Endocrinology Network, a leading online community for endocrinologists and other clinicians who treat patients with T2DM offers comprehensive and up-to-date coverage of the sodium glucose cotransporter 2 (SGLT2) inhibitors.
The Ensign Group, Inc., the parent company of the Ensign group of skilled nursing, rehabilitative care services and assisted living companies, today announced that its Board of Directors has declared a quarterly cash dividend of $0.06 per share of Ensign common stock, payable on or before January 31, 2012 to shareholders of record as of December 31, 2011.
› Verified 5 days ago
| Entity Name | Global Anesthesia Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013312412 PECOS PAC ID: 3173610466 Enrollment ID: O20150304000182 |
News Archive
Curemark, LLC,, a drug research and development company focused on the treatment of neurological diseases, announced that the company has opened clinical trial enrollment for CM-AT, its autism treatment, at the University of Pittsburgh and the Alexian Brothers Behavioral Health Hospital in Hoffman Estates, Illinois, near Chicago. A total of 12 sites nationwide are recruiting patients for CM-AT Phase III clinical trials.
A multicenter team of researchers has identified an enzyme key to the survival and spread of glioblastoma cancer cells that is not present in healthy brain cells, making the enzyme a promising therapeutic target.
A new preclinical model of pulmonary arterial hypertension may lead to improved research and ultimately better therapies for this life-threatening problem, according to its developers, researchers at the University of South Alabama.
UBM Medica US announces that Endocrinology Network, a leading online community for endocrinologists and other clinicians who treat patients with T2DM offers comprehensive and up-to-date coverage of the sodium glucose cotransporter 2 (SGLT2) inhibitors.
The Ensign Group, Inc., the parent company of the Ensign group of skilled nursing, rehabilitative care services and assisted living companies, today announced that its Board of Directors has declared a quarterly cash dividend of $0.06 per share of Ensign common stock, payable on or before January 31, 2012 to shareholders of record as of December 31, 2011.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Euisoo S Kim, MD 29 Creamery Ln, Easton, MD 21601-3137 Ph: (410) 819-0710 | Dr Euisoo S Kim, MD 7620 York Rd, Towson, MD 21204-7508 Ph: (410) 337-1660 |
News Archive
Curemark, LLC,, a drug research and development company focused on the treatment of neurological diseases, announced that the company has opened clinical trial enrollment for CM-AT, its autism treatment, at the University of Pittsburgh and the Alexian Brothers Behavioral Health Hospital in Hoffman Estates, Illinois, near Chicago. A total of 12 sites nationwide are recruiting patients for CM-AT Phase III clinical trials.
A multicenter team of researchers has identified an enzyme key to the survival and spread of glioblastoma cancer cells that is not present in healthy brain cells, making the enzyme a promising therapeutic target.
A new preclinical model of pulmonary arterial hypertension may lead to improved research and ultimately better therapies for this life-threatening problem, according to its developers, researchers at the University of South Alabama.
UBM Medica US announces that Endocrinology Network, a leading online community for endocrinologists and other clinicians who treat patients with T2DM offers comprehensive and up-to-date coverage of the sodium glucose cotransporter 2 (SGLT2) inhibitors.
The Ensign Group, Inc., the parent company of the Ensign group of skilled nursing, rehabilitative care services and assisted living companies, today announced that its Board of Directors has declared a quarterly cash dividend of $0.06 per share of Ensign common stock, payable on or before January 31, 2012 to shareholders of record as of December 31, 2011.
› Verified 5 days ago
Dr. Lewis Hogge, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 6701 N Charles St, Towson, MD 21204 Phone: 410-296-4616 Fax: 410-337-5068 | |
Deondra Patrice-simmons Asike, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6701 N Charles St # 4226, Towson, MD 21204 Phone: 410-296-4616 | |
Aloise Diedrich, Anesthesiology Medicare: Medicare Enrolled Practice Location: 6701 N Charles St, Towson, MD 21204 Phone: 443-849-2000 | |
Dr. John Yang, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6701 N Charles St, Towson, MD 21204 Phone: 410-296-4616 Fax: 410-337-5068 | |
William D. Zeichner, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6701 N Charles St, Towson, MD 21204 Phone: 512-574-5552 | |
Dr. Gary Michael Vita, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7505 Osler Dr, Towson, MD 21204 Phone: 410-337-5337 | |
Theodore Grabow, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8322 Bellona Ave, Suite 330, Towson, MD 21204 Phone: 410-825-6945 Fax: 410-825-8974 |